Quotes 5-day view Delayed Nasdaq
01/19/2021
01/20/2021
01/21/2021
01/22/2021
01/25/2021
Date
1.32(c)
1.23(c)
1.39(c)
1.4(c)
1.32(c)
Last
5 065 100
2 678 454
4 999 404
4 122 342
3 089 314
Volume
+8.20% -6.82% +13.01% +0.72% -5.71% Change
Sales 2020
67,9 M - -
Net income 2020
-28,4 M - -
Net cash position 2020
28,0 M - -
P/E ratio 2020
-3,33x
Yield 2020
-
Sales 2021
79,6 M - -
Net income 2021
-24,5 M - -
Net cash position 2021
27,0 M - -
P/E ratio 2021
-3,88x
Yield 2021
-
Capitalization
113 M 113 M -
EV / Sales 2020
1,26x
EV / Sales 2021
1,09x
Nbr of Employees
267
Free-Float
93,0%
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee.
Notations Surperformance© of Conformis, Inc.
Trading Rating : Investor Rating :
All news about CONFORMIS, INC.
News in other languages on CONFORMIS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CONFORMIS, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
4
Average target price
2,33 $
Last Close Price
1,32 $
Spread / Highest target
127%
Spread / Average Target
76,8%
Spread / Lowest Target
51,5%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
